048410.KQ
Hyundai Bioscience Co., Ltd.
KOE · Healthcare · Medical - Pharmaceuticals · KR
KRW 6,050.00
−0.49%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.63x
- Price / sales
- 174.98x
- Price / cash flow
- -34.89x
Enterprise value
- Enterprise value
- KRW 562.0B
- EV / sales
- 169.24x
- EV / EBITDA
- -31.50x
- EV / EBIT
- -29.17x
- Market cap
- KRW 581.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026